- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03493321
Role of PRF With MTA and Theracal After Pulpotomy in Relieving Pain
August 19, 2019 updated by: Sarah Essam, Cairo University
Role of PRF With MTA and Theracal After Pulpotomy in Relieving Pain and Maintaining the Vitality of the Remaining Radicular Pulp Tissue in Permanent Posterior Teeth With Closed Root Apices: "Randomized Controlled Trial"
this research will evaluate the effect of PRF with different bioactive materials in dentistry
Study Overview
Detailed Description
PRF will be used with MTA and Theracal to evaluate its effect upon these materials in reliving pain and maintains the teeth vitality in permanent teeth with closed apices, in order to improve the materials outcome.
Study Type
Interventional
Enrollment (Anticipated)
98
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 35 years (Child, Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients suffering from Symptomatic pulpitis.
- Patients should be free from any systemic disease that may affect normal healing and predictable outcome.
- Patients who will agree to the consent and will commit to follow-up period.
- Patients with mature root.
- Patients with no periapical lesion.
- Patients with localized pain.
- Posterior teeth only will be involved
Exclusion Criteria:
- Patients with immature roots.
- Patients with any systemic disease that may affect normal healing.
- Patients with periapical lesions or infections.
- Pregnant females.
- Patients who could/would not participate in a 1-year follow-up.
- Patients with fistula.
- Patients with necrotic pulp.
- Patients with old age.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: PRF with MTA
PRF with MTA with PRF with Theracal as intervention
|
using the PRF which is a new technique with an bioactive material which is the Theracal to evaluate its effect upon the radicular pulp tissue
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
pain after the process
Time Frame: 1 year
|
Questionnaire by asking the patient about the pain intensity
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
dentin bridge formation
Time Frame: 1 year
|
X-ray
|
1 year
|
no periapical radiolucency
Time Frame: 1 year
|
X-ray
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
August 22, 2019
Primary Completion (Anticipated)
August 22, 2019
Study Completion (Anticipated)
September 30, 2019
Study Registration Dates
First Submitted
March 12, 2018
First Submitted That Met QC Criteria
April 3, 2018
First Posted (Actual)
April 10, 2018
Study Record Updates
Last Update Posted (Actual)
August 20, 2019
Last Update Submitted That Met QC Criteria
August 19, 2019
Last Verified
August 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CEBD-CU-2018-03-07
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neuritis
-
Timothy UhlBluegrass OrthopedicsCompletedElbow Injuries and Disorders | Neuritis, Ulnar | Neuritis, Brachial | Neuritis; Nerve Root | Neuritis Median NerveUnited States
-
Medical University of ViennaUnknownOptic; Neuritis, With DemyelinationAustria
-
BiogenCompletedAcute Optic NeuritisSweden, Australia, Italy, Spain, United Kingdom, Germany, Belgium, Denmark, Hungary, Czech Republic, Canada
-
Fondation Ophtalmologique Adolphe de RothschildCompleted
-
BiogenCompletedAcute Optic NeuritisSweden, Spain, United Kingdom, Germany, Canada, Denmark, Hungary, Belgium, Czechia, Australia, Italy
-
Accure TherapeuticsSimbec ResearchCompletedOptic Neuritis | Optic; Neuritis, With DemyelinationUnited Kingdom
-
Novartis PharmaceuticalsTerminatedAcute Demylelinating Optic NeuritisUnited States, Spain
-
National Cancer Institute, EgyptCompletedThoracic NeuritisEgypt
-
OculisNeurotrialsRecruitingOptic Neuritis | Optic; Neuritis, With DemyelinationFrance
-
Haisco Pharmaceutical Group Co., Ltd.CompletedPHN - Post-Herpetic NeuritisChina
Clinical Trials on PRF with Theracal
-
Yuzuncu Yıl UniversityActive, not recruitingImpacted Third Molar ToothTurkey
-
Cairo UniversityUnknown
-
Cairo UniversityNot yet recruiting
-
British University In EgyptCompletedMaxillary Diseases
-
University of ChileRecruitingDental Implant Failed | Edentulous JawChile
-
Carol Davila University of Medicine and PharmacyCompletedDental Caries in ChildrenRomania
-
Universidade Estadual Paulista Júlio de Mesquita...UnknownTooth Loss | Recession, GingivalBrazil
-
Cairo UniversityUnknownAtrophy; Edentulous Ridge